DSpace at IIT Bombay >
IITB Publications >
Please use this identifier to cite or link to this item:
|Title: ||Labeling TiO(2) Nanoparticles with Dyes for Optical Fluorescence Microscopy and Determination of TiO(2)-DNA Nanoconjugate Stability|
|Authors: ||THURN, KT|
|Keywords: ||titanium-dioxide nanoparticles|
|Issue Date: ||2009|
|Publisher: ||WILEY-V C H VERLAG GMBH|
|Citation: ||SMALL, 5(11), 1318-1325|
|Abstract: ||Visualization of nanoparticles without intrinsic optical fluorescence properties is a significant problem when performing intracellular studies. Such is the case with titanium dioxide (TiO(2)) nanoparticles. These nanoparticles, when electronically linked to single-stranded DNA oligonucleotides, have been proposed to be used both as gene knockout devices and as possible tumor imaging agents. By interacting with complementary target sequences in living cells, these photoinducible TiO(2)-DNA nanoconjugates have the potential to cleave intracellular genomic DNA in a sequence specific and inducible manner. The nanoconjugates also become detectable by magnetic resonance imaging with the addition of gadolinium Gd(III) contrast agents. Herein two approaches for labeling TiO(2) nanoparticles and TiO(2)-DNA nanoconjugates with optically fluorescent agents are described. This permits direct quantification of fluorescently labeled TiO(2) nanoparticle uptake in a large population of living cells (>10(4) cells). X-ray fluorescence microscopy (XFM) is combined with fluorescent microscopy to determine the relative intracellular stability of the nanoconjugates and used to quantify intracellular nanoparticles. Imaging the DNA component of the TiO(2)-DNA nanoconjugate by fluorescent confocal microscopy within the same cell shows an overlap with the titanium signal as mapped by XFM. This strongly implies the intracellular integrity of the TiO(2)-DNA nanoconjugates in malignant cells.|
|Appears in Collections:||Article|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.